Home workouts may boost prostate cancer Patients' Well-Being

NCT ID NCT07126860

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a structured home-based exercise program combining strength and aerobic training can improve quality of life, fitness, and immune function in 150 men with prostate cancer. Participants are randomly assigned to either the exercise program or usual care. The program uses resistance bands and bodyweight exercises, with training 3-6 days per week for at least 12 weeks. The goal is to see if exercise can reduce side effects like fatigue, muscle loss, and depression.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
structured combined resistance and aerobic training
What this could lead to
If it works, this could provide a simple, home-based exercise program to improve quality of life and physical fitness for men with prostate cancer.
What could go wrong
This is a relatively small, early-stage study (150 participants) testing a behavioral intervention, so results may not be generalizable. Participants must be motivated to exercise 3-6 days per week, and adherence may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic prostate carcinoma Motor Activity prostate cancer Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ludwig Maximilian University Hospital Campus Großhadern

    Munich, Bavaria, 81377, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.